Positive correlation between standardized uptake values of FDG uptake in the stomach and the value of the C-13 urea breath test

Clinical Nuclear Medicine

Volumn 31, Issue 12, 2006, Pages 792-794

  Lin, Chun Yi ^a,c   Liu, Chiu Shoung ^a   Ding, Hueisch Jy ^b   Sun, Shung Shung ^a   Yen, Kuo Yang ^a   Hsieh, Te Chun ^a   Lin, Cheng Chieh ^a   Kao, Chia Hung ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

C 13 urea reath test (UBT); FDG PET; Helicobacter pylori (HP); Standardized uptake values (SUVs)

Indexed keywords

CARBON 13; FLUORODEOXYGLUCOSE F 18; UNCLASSIFIED DRUG; UREA; UREA C 14;

ARTICLE; CLINICAL ARTICLE; COMMUNITY MEDICINE; CORRELATION ANALYSIS; DRUG UPTAKE; GASTRITIS; GOLD STANDARD; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; STOMACH CANCER; STOMACH WALL; UREA BREATH TEST;

BREATH TESTS; CARBON ISOTOPES; FEMALE; FLUORODEOXYGLUCOSE F18; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS; STOMACH; UREA;

EID: 33751200925     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000247742.52969.6b     Document Type: Article

References (12)

1. Salaun PY, Grewal RK, Dodamane I, et al. An analysis of the 18F-FDG uptake pattern in the stomach. J Nucl Med. 2005;46:48.
2. Castellucci P, Nanni C, Farsad M, et al. Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation. Nucl Med Commun. 2005;26:689.
3. Stahl A, Ott K, Schwaiger M, et al. Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET. Eur J Nucl Med Mol Imaging. 2004;31:1471. Epub 2004 Jul 15.
4. Yeung HW, Macapinlac H, Karpeh M, et al. Accuracy of FDG-PET in gastric cancer. Preliminary experience. Clin Positron Imaging. 1998;1:213.
5. Montravers F, Kerrou K, Grahek D, et al. Value of [18F]- fluorodeoxyglucose (FDG) positron emission tomography in digestive cancerology. Presse Med. 2002;31:1560.
6. Sheu BS, Lee SC, Yang HB, et al. Quantitative result of 13C urea breath test at 15 minutes may correlate with the bacterial density of H. pylori in the stomach. Hepatogastroenterology. 1999;46:2057.
7. El-Haddad G, Zhuang H, Gupta N, et al. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med. 2004;34:313.
8. Mochiki E, Kuwano H, Katoh H, et al. Evaluation of 18F-2-deoxy-2-fluoro- D-glucose positron emission tomography for gastric cancer. World J Surg. 2004;28:247. Epub 2004 Feb 17.
9. Yun M, Choi HS, Yoo E, et al. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. J Nucl Med. 2005;46:953.
10. Kuo FC, Wang SW, Wu IC, et al. Evaluation of urine ELISA test for detecting Helicobacter pylori infection in Taiwan: a prospective study. World J Gastroenterol. 2005;11:5545.
11. Yei CJ, Chang JG, Shih MC, et al. Lewis blood genotypes of peptic ulcer and gastric cancer patients in Taiwan. World J Gastroenterol. 2005;11:4891.
12. Koga H, Sasaki M, Kuwabara Y, et al. An analysis of the physiological FDG uptake pattern in the stomach. Ann Nucl Med. 2003;17:733.